Keyphrases
Working Memory Deficits
100%
Mouse Model
100%
Antipsychotics
100%
Schizophrenia Models
100%
Parvalbumin Interneurons
100%
Prelimbic Cortex
75%
Schizophrenia
50%
Parvalbumin Neurons
50%
Cognitive Deficits
50%
Chemogenetics
50%
Olanzapine
50%
In Vivo Calcium Imaging
50%
Dopamine D2 Receptor Occupancy
50%
Hyperactivity
25%
Parvalbumin
25%
Striatum
25%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
25%
Patients with Schizophrenia
25%
Histological Analysis
25%
Excitatory Synapse
25%
High Risk
25%
Dendritic Spines
25%
Neural Circuits
25%
Behavior Analysis
25%
Unmet Medical Need
25%
Therapeutic Intervention
25%
Synaptic Dysfunction
25%
Animal Model of Schizophrenia
25%
Phencyclidine
25%
Neural Mechanisms
25%
Imaging Analysis
25%
Pyramidal Neurons
25%
Inhibitory Synapse
25%
GABAergic Interneurons
25%
Continuous Administration
25%
Potential Therapeutic Strategies
25%
Relapse Risk
25%
Circuit Mechanisms
25%
Therapeutic Window
25%
Vesicular Glutamate Transporter
25%
Occupancy Analysis
25%
Dimensional Approach
25%
Psychomotor
25%
Neuroscience
Amnesia
100%
Parvalbumin
100%
Interneuron
100%
Antipsychotic
100%
Working Memory
100%
In Vivo
75%
Cognitive Disorders
50%
Calcium Imaging
50%
Dopamine Receptor D2
50%
Olanzapine
50%
Receptor Occupancy
50%
Synapse
25%
Hyperactivity
25%
Striatum
25%
Dendritic Spine
25%
Neural Circuit
25%
Phencyclidine
25%
Typical Antipsychotic
25%
Liquid Chromatography-Mass Spectrometry
25%
Vesicular Glutamate Transporter 1
25%
Pharmacology, Toxicology and Pharmaceutical Science
Parvalbumin
100%
Mouse Model
100%
Amnesia
100%
Antipsychotic
100%
Cognitive Defect
50%
Dopamine Receptor D2
50%
Olanzapine
50%
Phencyclidine
25%
Hyperactivity
25%
Typical Antipsychotic
25%
Therapeutic Window
25%
Vesicular Glutamate Transporter 1
25%